(Q47834955)

6 February 2018

title

Effects of sevoflurane or ketamine on the QTc interval during electroconvulsive therapy (English)

1 reference

6 February 2018

1 reference

Feray Erdil

1

1 reference

6 February 2018

Zekine Begeç

2

1 reference

6 February 2018

Gülay Erdoğan Kayhan

3

1 reference

6 February 2018

Saim Yoloğlu

4

1 reference

6 February 2018

Mehmet Özcan Ersoy

5

1 reference

6 February 2018

Mahmut Durmuş

6

1 reference

6 February 2018

publication date

2 August 2014

1 reference

6 February 2018

published in

Journal of Anesthesia

1 reference

6 February 2018

volume

29

1 reference

6 February 2018

issue

2

1 reference

6 February 2018

page(s)

180-185

1 reference

6 February 2018

A comparison of the effect on dispersion of repolarization of age-adjusted MAC values of sevoflurane in children.

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00540-014-1899-2

The effects of propofol and sevoflurane on the QT interval and transmural dispersion of repolarization in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-014-1899-2

The effects of droperidol and ondansetron on dispersion of myocardial repolarization in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-014-1899-2

Comparison of seizure duration, ictal EEG, and cognitive effects of ketamine and methohexital anesthesia with ECT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-014-1899-2

Rapid antidepressant effect of ketamine anesthesia during electroconvulsive therapy of treatment-resistant depression: comparing ketamine and propofol anesthesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-014-1899-2

Augmentation strategies in electroconvulsive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-014-1899-2

The clinical utility of inhalational anesthesia with sevoflurane in electroconvulsive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-014-1899-2

Sevoflurane causes greater QTc interval prolongation in elderly patients than in younger patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-014-1899-2

Sevoflurane progressively prolongs the QT interval in unpremedicated female adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-014-1899-2

Sevoflurane, but not propofol, significantly prolongs the Q-T interval

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-014-1899-2

The Duration of Systole in an Electrocardiogram in Normal Humans and in Patients with Heart Disease*

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-014-1899-2

Cellular basis for the normal T wave and the electrocardiographic manifestations of the long-QT syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-014-1899-2

Cellular basis for QT dispersion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-014-1899-2

Measurement of the QT interval and the risk associated with QTc interval prolongation: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-014-1899-2

Assessment of QT interval and QT dispersion during electroconvulsive therapy using computerized measurements.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-014-1899-2

The utility of ketamine in facilitating the induction of isoproterenol-refractory idiopathic ventricular tachyarrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-014-1899-2

Prolonged QT syndrome and sedation: a case report and a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-014-1899-2

Sustained prolongation of the QTc interval after anesthesia with sevoflurane in infants during the first 6 months of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-014-1899-2

Mechanisms underlying the QT interval-prolonging effects of sevoflurane and its interactions with other QT-prolonging drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-014-1899-2

Myocardial ischemia revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-014-1899-2

Anesthesia for electroconvulsive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-014-1899-2

The comparative effects of sevoflurane and methohexital for electroconvulsive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-014-1899-2

Effects of propofol and ketamine as combined anesthesia for electroconvulsive therapy in patients with depressive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-014-1899-2

Ketofol in electroconvulsive therapy anesthesia: two stones for one bird.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-014-1899-2

QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients

21 January 2018

1 reference

12 December 2020

Propofol alone, sevoflurane alone, and combined propofol-sevoflurane anaesthesia in electroconvulsive therapy.

1 reference

12 December 2020

Long QT syndrome and anaesthesia

1 reference

12 December 2020

QT dispersion in the surface electrocardiogram in elderly patients with major depression

1 reference

12 December 2020

The current status of seizure duration in the practice of electroconvulsive therapy

1 reference

12 December 2020

The effect of electroconvulsive therapy on QT dispersion

1 reference

12 December 2020

Prolonged QT-interval syndromes

1 reference

12 December 2020

Cardiovascular complications of ECT in depressed patients with cardiac disease

1 reference

12 December 2020

10.1007/S00540-014-1899-2

Identifiers

DOI

1 reference

6 February 2018

PubMed ID

25085036

1 reference

6 February 2018